Carregant...

Disease activity in pregnancy and postpartum in women with MS who suspended rituximab and natalizumab

OBJECTIVE: To evaluate risks of disease reactivity during pregnancy and postpartum following rituximab (RTX) and natalizumab (NTZ) suspension in women with MS. METHODS: An observational cohort study of all women with MS disease onset before childbirth between 2006 and 2017. Women were identified thr...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neurol Neuroimmunol Neuroinflamm
Autors principals: Razaz, Neda, Piehl, Fredrik, Frisell, Thomas, Langer-Gould, Annette M., McKay, Kyla A., Fink, Katharina
Format: Artigo
Idioma:Inglês
Publicat: Lippincott Williams & Wilkins 2020
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7641107/
https://ncbi.nlm.nih.gov/pubmed/33087582
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/NXI.0000000000000903
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!